Today, investors in Editas Medicine and EDIT stock are pricing in some clinical trial results that are being viewed negatively by the market. More
Articles
Blackberry Provides an Interesting Long-Term Opportunity After Q2 Earnings
A few years into a major restructuring, Blackberry is yet to show real progress in its results. Still, BB stock could be a long-term winner. More
FuboTV Is Undervalued Based on Its Ad Business’ Potential
FUBO stock has a huge subscriber base, which is complimented by its fast-growing ad business that provides a lot of dividends in the future. More
6 Things for Potential PALT Stock Investors to Know About Social Video Play Paltalk as Shares Take Off
Paltalk (PALT) is rocketing higher on Wednesday as traders flock to the stock following an update from the company today. More
GameStop Stock Might Have Some Long-Term Juice Left
With a crucial holiday quarter approaching after a roller coaster first half of 2021, here's where meme classic GME stock may go next. More
Why Robinhood Stock Will Earn More Praise Over Time
HOOD stock user metrics tell of a good future. Wall Street investors simply need time to trust it, so owning some stock is a valid thesis. More
